Showing results (101-110 of 138) with videos related to
Sort By:
Pageof 14
Clinical Pharmacokinetics|February 18, 2018
Impact of Boosted Antiretroviral Therapy on the Pharmacokinetics and Efficacy of Clopidogrel and Prasugrel Active MetabolitesNiloufar Marsousi, Youssef Daali, Pierre Fontana, et al.Neuropharmacology|December 15, 2010
HZ166, a novel GABAA receptor subtype-selective benzodiazepine site ligand, is antihyperalgesic in mouse models of inflammatory and neuropathic painAlessandra Di Lio, Dietmar Benke, Marie Besson, et al.European Journal of Pain (London, England)|November 20, 2019
Perioperative intravenous low-dose ketamine for neuropathic pain after major lower back surgery: A randomized, placebo-controlled studyChristoph Czarnetzki, Jules Desmeules, Enrico Tessitore, et al.Journal of Personalized Medicine|October 28, 2025
Molecular Profiling of SYT-SSX Fusion Transcripts for Enhanced Diagnosis of Synovial SarcomasSara Louati, Kaoutar Bentayebi, Ibtissam Saad, et al.Pharmacological Research|July 6, 2016
Screening for genotypic and phenotypic variations in CYP450 activity in patients with therapeutic problems in a psychiatric setting, a retrospective studyCélia Lloret-Linares, Victoria Rollason, Kuntheavy Ing Lorenzini, et al.Rapid Communications in Mass Spectrometry : RCM|May 18, 2012
A simplified method for busulfan monitoring using dried blood spot in combination with liquid chromatography/tandem mass spectrometryMarc Ansari, Chakradhara Rao S Uppugunduri, Julien Déglon, et al.Basic & Clinical Pharmacology & Toxicology|February 3, 2023
Evaluation of important human CYP450 isoforms and P-glycoprotein phenotype changes and genotype in type 2 diabetic patients, before and after intensifying treatment regimen using Geneva cocktailNavid Neyshaburinezhad, Nooshin Shirzad, Mohammadreza Rouini, et al.Journal of Personalized Medicine|April 23, 2022
Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World SettingCamille Lenoir, Jean Terrier, Yvonne Gloor, et al.CPT: Pharmacometrics & Systems Pharmacology|October 5, 2023
Apixaban and rivaroxaban's physiologically-based pharmacokinetic model validation in hospitalized patients: A first step for larger use of a priori modeling approach at bed sideJean Terrier, Frédéric Gaspar, Pauline Gosselin, et al.British Journal of Clinical Pharmacology|September 9, 2020
Impact of enantiomer-specific changes in pharmacokinetics between infants and adults on the target concentration of racemic ketorolac: A pooled analysisMichael E Cloesmeijer, Michiel J van Esdonk, Anne M Lynn, et al.Pageof 14